Recent Advancements on the Use of Exosomes as Drug Carriers for the Treatment of Glioblastoma
Glioblastoma (GBM) is the most common and aggressive cancer of the brain. Presently, GBM patients have a poor prognosis, and therapy primarily aims to extend the life expectancy of affected patients. The current treatment of GBM in adult cases and high-grade gliomas in the pediatric population invol...
Main Authors: | Angela Galardi, Alexander De Bethlen, Virginia Di Paolo, Silvia Lampis, Angela Mastronuzzi, Angela Di Giannatale |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/13/4/964 |
Similar Items
-
Exosomes: Novel Bio-Inspired Nanocarriers for Efficient Targeting of Glioblastoma Tumor Cells
by: V Taghdiri Nooshabadi, et al.
Published: (2021-03-01) -
The Involvement of Exosomes in Glioblastoma Development, Diagnosis, Prognosis, and Treatment
by: Adrian Bălașa, et al.
Published: (2020-08-01) -
Advances in exosome-related biomarkers for glioblastoma: Basic research and clinical application
by: Yuzhen Jiang, et al.
Published: (2018-01-01) -
Impact of atorvastatin loaded exosome as an anti-glioblastoma carrier to induce apoptosis of U87 cancer cells in 3D culture model
by: Vajihe Taghdiri Nooshabadi, et al.
Published: (2020-09-01) -
Proteome of Glioblastoma-Derived Exosomes as a Source of Biomarkers
by: Stanislav Naryzhny, et al.
Published: (2020-07-01)